Ziad El Husseini

Ziad El Husseini, M.D. is a Professor of Oncology at the University of Texas Southwestern Medical Center School of Medicine. He maintains clinical and research affiliations with the VA North Texas Care System and Dallas VA Medical System. His career spans from early specialization in ophthalmology to current focus on oncology, particularly gastrointestinal cancers.

Dr. El Husseini earned his Medical Degree from the American University of Beirut in 1986, followed by an Ophthalmology Internship (1987) and Residency (1990) at the same institution. He completed a Glaucoma Fellowship at Kentucky Lions Research Institute (1991), then moved to UT Southwestern Medical Center for an Ophthalmology Internship (1992), Residency (1995), and Oculoplastic Surgery Fellowship (1996).

His research interests focus on innovative cancer treatments, particularly in rectal and bladder cancers. His work examines combination therapies involving radiation, chemotherapy, and immunotherapy, with emphasis on treatment efficacy and safety profiles. Recent publications highlight his leadership in clinical trials exploring novel approaches to locally advanced rectal adenocarcinoma and muscle-invasive bladder cancer.

Dr. El Husseini's publication record demonstrates a transition from ophthalmology research in his early career to oncology-focused work in recent years. His research shows particular strength in clinical trial design, treatment protocol development, and therapeutic efficacy assessment across multiple cancer types.

His work has appeared in prestigious journals including European Journal of Cancer, International Journal of Molecular Sciences, BMC Cancer, and Journal of Infection and Development of Countries, reflecting the interdisciplinary nature of his research spanning oncology, immunology, and clinical medicine.